Market Overview

5 Biggest Price Target Changes For Thursday

Related RARE
The Daily Biotech Pulse: Syndax Lung Cancer Trial Disappoints, Gemphire To Trim Workforce, Opiant's Offering
The Daily Biotech Pulse: Novartis Divestment, Eyepoint's Drug Gets Coverage, Spectrum's Robust Data
Related FDX
The Week Ahead: Nike Earnings, FDA Debates E-Cig Industry, SurveyMonkey IPOs
Benzinga's Top Upgrades, Downgrades For September 21, 2018
Amazon Has $7.9 Billion Reasons To Buy 20,000 Vans (Seeking Alpha)
  • Wedbush lowered Ultragenyx Pharmaceutical Inc (NASDAQ: RARE) price target from $88 to $80. Ultragenyx Pharmaceutical shares closed at $78.36 on Wednesday.
  • Baird raised FedEx Corporation (NYSE: FDX) price target from $209 to $222. FedEx shares closed at $195.92 on Wednesday.
  • Barclays increased the price target for Cintas Corporation (NASDAQ: CTAS) from $130 to $145. Cintas shares closed at $124.37 on Wednesday.
  • Citi raised the price target for Nike Inc (NYSE: NKE) from $60 to $66. Nike shares closed at $53.92 on Wednesday.
  • UBS increased PVH Corp (NYSE: PVH) price target from $112 to $116. PVH shares closed at $90.85 on Wednesday.

Latest Ratings for RARE

Sep 2018Bank of AmericaMaintainsBuyBuy
Sep 2018Morgan StanleyAssumesEqual-Weight
Aug 2018WedbushMaintainsOutperformOutperform

View More Analyst Ratings for RARE
View the Latest Analyst Ratings

Posted-In: Price Target ChangesPrice Target Analyst Ratings


Related Articles (CTAS + FDX)

View Comments and Join the Discussion!

Gadfly's Nisen: Valeant's 'Financial Wizardry' Doesn't Change The Long-Term Outlook

Insys Surrenders Some Early Gains After Synros Announced As A Schedule 11 Drug